Use of InflammaDry® for MMP-9 detection in ocular graft versus host disease

MK Morrow, R Johnson, J Jerkins… - JOURNAL OF BONE …, 2023 - jbmtct.com.br
Background: InflammaDry® is a point-of-care test that can detect matrix metalloproteinase-9
(MMP-9), an inflammatory biomarker that is elevated in ocular surface stress and …

Conjunctival Matrix Metalloproteinase‐9 Clinical Assessment in Early Ocular Graft versus Host Disease

L Berchicci, E Aragona, A Arrigo… - Journal of …, 2021 - Wiley Online Library
Purpose. Graft versus Host Disease (GVHD) typically affects the ocular surface, with a
presentation resembling Dry Eye Disease (DED). Although the etiopathology is not …

[HTML][HTML] The Matrix Metalloproteinase-9 Point-of-Care Test for Dry Eye Disease

DH Kim - Annals of Optometry and Contact Lens, 2022 - annocl.org
안구건조증은 눈물막 이상과 안구 불편감을 특징으로 하며, 안구표면 염증이 주요 병인이다.
최근 InflammaDry 라는 눈물 내 기질 금속단백분해효소 9 검사 (MMP-9) 가 일상적인 임상 …

Elevated neutrophil elastase in tears of ocular graft-versus-host disease patients

SN Arafat, MC Robert, T Abud, S Spurr-Michaud… - American Journal of …, 2017 - Elsevier
Purpose To investigate the levels of neutrophil elastase (NE), matrix metalloproteinases
(MMPs), and myeloperoxidase (MPO) in tear washes of patients with ocular graft-vs-host …

Conjunctival inflammation and dry eye symptoms at day 100 post-transplantation do not predict risk for chronic graft-versus-host disease

AM Shah, A Galor, K Mones, P Jean… - Taiwan journal of …, 2023 - journals.lww.com
PURPOSE: Chronic graft-versus-host disease (cGVHD) is a significant cause of morbidity
and mortality among patients after allogeneic hematopoietic stem cell transplant (HCT). The …

P1342: A SCREENING TOOL TO DETECT CHRONIC OCULAR GRAFT VERSUS HOST DISEASE IN A HEMATOLOGY/ONCOLOGY OUTPATIENT SETTING

E Greenan, E Vandenberghe, E Conneally… - …, 2022 - journals.lww.com
Background: Chronic ocular GvHD (oGvHD) is reported to occur in 30-60% of patients after
hematological stem cell transplantation (HSCT). Presently, there is no diagnostic test …

Tear cytokine profiling for ocular graft versus host disease utilizing a new multiplex assay

AJ Li, F Martinez-Guasch, S Sajjan, X Cao… - The Journal of …, 2023 - journals.aai.org
Many patients who have undergone allogeneic hematopoietic stem cell transplantation
(aHSCT) as part of cancer therapy achieve remission. However, nearly 50% of these …

[HTML][HTML] Ocular Graft vs Hosts Disease (oGVHD) After Allogenic Hematopoietic Stem Cell Transplant (allo-HSCT): A 2 Year Longitudinal, Observational Study

N Atassi, B Surenkhuu, J Mun, C Berek… - … & Visual Science, 2021 - iovs.arvojournals.org
Purpose: To determine the pre-existing ocular findings that predispose to developing
oGVHD in patients following allo-HSCT and evaluate the benefits of early treatment …

Clinical Study on Cytokines Panel in the Diagnosis of Ocular Chronic Graft-Versus-Host Disease

X Cheng, R Ji, R Huang, S Huang, W Fan, Y Zhao… - Blood, 2023 - Elsevier
Background Chronic graft-versus-host disease (cGVHD) is a common complication after
allogeneic hematopoietic stem cell transplantation (allo-HSCT), affecting 30-70% of patients …

Changes in the matrix metalloproteinase 9 point-of-care test positivity according to MMP-9 concentration and loading volume

J Huh, SY Choi, Y Eom, HM Kim, JS Song - Cornea, 2020 - journals.lww.com
Purpose: To measure changes in the matrix metalloproteinase 9 (MMP-9) point-of-care test,
InflammaDry (Rapid Pathogen Screening, Inc, Sarasota, FL) positivity, based on ocular …